It is a combined antibiotic (kanamycin) and mucolytic (Acetyl cysteine) agents.
Kanamycin is an aminoglycoside antibiotic with bactericidal activity.
It inhibits bacterial protein synthesis via binding to 30S ribosome.
It is active against Gram negative bacteria (Ecoli, Salmonella Spp.. Klebsiella Spp., Pseudomonas aerugenosa, Bordetella bronchiseptica & Pasteurella Spp.) and has activity against Staphylococcus aureus and other Staphylococcus spp.
Acetylcysteine decreases viscosity of secretions and is used as mucolytic agent in eyes and in
bronchial nebulizing Solutions.
It is a sulfhydryl compound acts to increase synthesis of glutathione in the liver.
Route: By I/M(horses). S/C Injection (Dogs) For active ingredient: Horses: 6000 7500 IU kanamycin sulfate + 6-7.5 mg N-acetyl-L-cysteine kg b.wt by I/M injection every 12 hours for 2-3 days. Dags: 11250 - 15000 IU kanamycin suling.
injection every 12 hours for 2-3 days. 1935, 45 mg N-acetyl-cysteine/kg/ b.wt by S/C.
Horses: 8-10 ml of product / 100 kg bwt. by I/M injection every 12 hours for 2-3 days. Dogs: 8-10 ml of product / 100 kg bwt. by I/M injection every 12 hours for 2-3 days.
• Do not be used with nephrotoxic drugs such as aminoglycoside antibiotics, polimixira, colistin,
cephaloridine, general anesthetics and muscle relaxants.
• Do not administer to equine animals producing milk for human consumption.
• Do not use in animals with renal disease.
• Do not use in dehydrated animals.
Nephrotoxicity is the most dose limiting toxicity.
Ensure that patients have adequate fluid and electrolyte balance during therapy.
* Ototoxicity and vestibulotoxicity also are possible.